Unidad de Parkinson y Trastornos del Movimiento Instituto Clínic de Neurociencias, Hospital Clinic de Barcelona
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Marti, Maria Jose
NCT03763604: Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Approved for marketing
N/A
Europe, Canada, RoW
Abemaciclib, LY2835219
Eli Lilly and Company
Metastatic Breast Cancer
 
 
FEEMSA, NCT04706234: Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies

Recruiting
N/A
200
Europe, Japan, RoW
Kliniken Beelitz GmbH, University Hospital Muenster, Medical University of Warsaw, University Hospital Carl Gustav Carus, University of Ulm, Medical University Innsbruck, Hannover Medical School, University of Barcelona
Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy
12/23
07/24
PPMI, NCT04477785: Clinical - Establishing a Deeply Phenotyped PD Cohort

Recruiting
N/A
4500
Europe, Canada, US, RoW
Michael J. Fox Foundation for Parkinson's Research, Institute for Neurodegenerative Disorders
Parkinson Disease
12/33
12/33
Vilaseca, Isabel
FEEMSA, NCT04706234: Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies

Recruiting
N/A
200
Europe, Japan, RoW
Kliniken Beelitz GmbH, University Hospital Muenster, Medical University of Warsaw, University Hospital Carl Gustav Carus, University of Ulm, Medical University Innsbruck, Hannover Medical School, University of Barcelona
Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy
12/23
07/24

Download Options